Evidence map›Paper›PMID 40066790›Full record

ArticleJournal of cellular and molecular medicine2025

Rapid Development of Unclassified Myeloid Lineage Acute Leukaemia With Trisomy 6 and U2AF1 Mutation.

Miroslaw Markiewicz, Agnieszka Kopacz, Beata Blajer-Olszewska, Malwina Mazur, Katarzyna Warzybok, Marta Szarawarska, Marzena Wojtaszewska, Monika Moskwa, Dominika Dudycz, Ewa Schwarz and 2 more

Abstract readCase Reports
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Miroslaw MarkiewiczDepartment of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland.ORCID 0000-0002-8550-8908
Agnieszka KopaczHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Beata Blajer-OlszewskaHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Malwina MazurHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Katarzyna WarzybokHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Marta SzarawarskaHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Marzena WojtaszewskaHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Monika MoskwaHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Dominika DudyczHematology Department, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Ewa SchwarzClinic of Tuberculosis and Lung Diseases, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Katarzyna KosiorClinical Department of Pathomorphology, Frederic Chopin University Clinical Hospital, Rzeszow, Poland.
Krzysztof LewandowskiFaculty of Medicine, Division of Laboratory Medicine, Medical University of Gdansk, Gdansk, Poland.

Funding

Uniwersytet Rzeszowski
6 · The paper itself

Abstract

We present a case of acute clonal bone marrow 98% infiltration of atypical myeloid cells with borderline hypogranular/agranular promyelocytes/myelocytes and occasional blast cells maturity, which also formed extramedullary tumours in the chest wall, with isolated trisomy of chromosome 6 and pathogenic variant U2AF1 (S34F) that escapes established acute myeloid leukaemia (AML) diagnostic criteria according to the World Health Organization (WHO) classification. Following standard daunorubicin and cytarabine induction therapy, the disease progressed with the appearance of a previously undetected clone of leukaemic cells with a distinct immunophenotype demonstrating monocytoid differentiation and clonal evolution to a hypo-tetraploid karyotype with an average number of 84 chromosomes and new pathogenic NRAS and ZRSR2 mutations. The patient reactivated refractory disseminated intravascular coagulation (DIC) leading to a progressive supratentorial hematoma and finally cardiac arrest. In conclusion, our report shows that atypical clonal myelocytes can massively infiltrate the bone marrow and form extramedullary tumours, justifying the diagnosis and treatment of acute leukaemia, although they did not fit the current classification.

Indexed as

Chromosomes, Human, Pair 6Leukemia, Myeloid, AcuteMutationSplicing Factor U2AFTrisomyHumansMaleMiddle AgedSplicing Factor U2AFU2AF1 protein, humanAML‐molecular diagnosis & therapycytogeneticsimmunophenotypemyelopoiesis

Identifiers

PMID40066790
PMCPMC11894460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.